glp-1 compounding news LegitScript's Data Reveals 1200% Increase in Violative and Problematic Advertisements for Medications Weight-Loss Drugs Are Everywhere Now.

doi: 10.1016/j.brainres.2012.07.029 [DOI] [PubMed] [Google Scholar] 168

3 recent developments validating the active compounded GLP-1 market: 1

While both Lixisenatide and Liraglutide are well-tolerated, the former is superior at lowering weight and improving blood glucose levels [248], [249], [250], [251]

What has become increasingly clear since 2023 is that GLP-1 receptors are also active in areas of the brain involved in reward, impulse control, motivation, and stress regulation

[DOI] [PMC free article] [PubMed] [Google Scholar] 41.Kanoski SE, Hayes MR, and Skibicka KP, GLP-1 and Weight Loss: Unraveling the Diverse Neural Circuitry, American Journal of Physiology

[DOI] [PubMed] [Google Scholar] 114.Kim M.H., Jee J.H., Park S., Lee M.S., Kim K.W., Lee M.K